Alzheimer's, Dementia & Cognitive Neurology Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
Sign in | Subscribe | Recommend to Library
New to F1000? See this week’s top article below for a free preview of a Recommendation.
SECTION HEADS
-
Fondation Ipsen, Paris, France
-
Department of Psychiatry & Behavioral Sciences, Duke University Medical Center, Durham, NC, USA
-
Departments of Neurology and Psychiatry, School of Medicine, University of California, San Francisco (UCSF), San Francisco, CA, USA
-
Department of Neurology and Alzheimer Center, VU University Medical Center, Amsterdam, Netherlands
-
Department of Psychiatry, University of Rochester Medical Center, Rochester, NY, USA
Section Topics
- » Alzheimer's disease
- » Amnesia
- » Aphasia
- » Apraxia
- » Confusional states
- » Dementia
- » Frontal lobe syndromes
- » Frontotemporal dementia
- » Mild cognitive impairment
- » Prion disorders
LATEST RECOMMENDATION
Leo Verhagen and Brandon Barton, Rush University Medical Center, USA. F1000 Neurological Disorders
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
1 Recommendation, most recent by
Magdy Selim and Richard Goddeau, Beth Israel Deaconess Medical Center, USA. F1000 Neurological Disorders
- New Finding
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
